Category C—A case study of 26 infants exposed to fluvoxamine in utero reported that exposure was not associated with increased risk of malformations, lower birth weights, or younger gestational age.
RID 1-2%; ∅AE's have been reported
Consider a lower dose, titrate slower.
No dosage adjustment necessary.
No dosage adjustments in manufacturer's labeling. Limited data suggest clearance ↓ in patients with impairment